Report overview
Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells.
As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes - Capricor, Puretech and Reneuron, none of the company's products have actually been used in clinical practice.
This report contains market size and forecasts of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in Global, including the following market information:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies include Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd and Cellular Biomedicine Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Type, 2021 (%)
Type I
Type II
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Application, 2021 (%)
Diagnostics
Therapies
Skincare
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tianjin Angsai Cell Genetic Engineering Co. Ltd
Qingdao Aoke Biological Development Co. Ltd
Beijing SH biotechnology Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Shanghai Aisar Biotechnology Co. Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Beijing Han's United Biotechnology Co. Ltd
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Cellular Biomedicine Group
Guangzhou Celera Stem Cell Technology Co. Ltd.
Stem Med Pte Ltd
CryoCord Sdn Bhd
Cytopeutics Sdn Bhd
Stempeutics Research Pvt Ltd
Asian Institute of Gastroenterology
